XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2022 $ 204,954 $ 44 $ 523,921 $ (318,790) $ (221)
Beginning Balance, Shares at Dec. 31, 2022   44,105,981      
Issuance of common stock in accordance with Gilead Stock Purchase Agreement, value 115,270 $ 4 115,266    
Issuance of common stock in accordance with Gilead Stock Purchase Agreement, shares   3,478,261      
Exercise of stock options, value 374   374    
Exercise of stock options, shares   34,713      
Issuance of common stock from vesting of restricted stock, shares   222,433      
Share-based compensation 10,156   10,156    
Unrealized gain (loss) on marketable securities 307       307
Net Income (Loss) (27,344)     (27,344)  
Ending Balance at Mar. 31, 2023 303,717 $ 48 649,717 (346,134) 86
Ending Balance, shares at Mar. 31, 2023   47,841,388      
Beginning Balance at Dec. 31, 2022 204,954 $ 44 523,921 (318,790) (221)
Beginning Balance, Shares at Dec. 31, 2022   44,105,981      
Net Income (Loss) (90,534)        
Ending Balance at Sep. 30, 2023 266,128 $ 48 675,469 (409,324) (65)
Ending Balance, shares at Sep. 30, 2023   48,673,675      
Beginning Balance at Mar. 31, 2023 303,717 $ 48 649,717 (346,134) 86
Beginning Balance, Shares at Mar. 31, 2023   47,841,388      
Exercise of stock options, value 2,965   2,965    
Exercise of stock options, shares   398,861      
Issuance of common stock from vesting of restricted stock, shares   46,593      
Issuance of common stock pursuant to employee stock purchase plan, value 528   528    
Issuance of common stock pursuant to employee stock purchase plan, Shares   28,549      
Share-based compensation 10,404   10,404    
Unrealized gain (loss) on marketable securities (93)       (93)
Net Income (Loss) (23,854)     (23,854)  
Ending Balance at Jun. 30, 2023 293,667 $ 48 663,614 (369,988) (7)
Ending Balance, shares at Jun. 30, 2023   48,315,391      
Exercise of stock options, value 1,241   1,241    
Exercise of stock options, shares   343,263      
Issuance of common stock from vesting of restricted stock, shares   15,021      
Share-based compensation 10,614   10,614    
Unrealized gain (loss) on marketable securities (58)       (58)
Net Income (Loss) (39,336)     (39,336)  
Ending Balance at Sep. 30, 2023 266,128 $ 48 675,469 (409,324) (65)
Ending Balance, shares at Sep. 30, 2023   48,673,675      
Beginning Balance at Dec. 31, 2023 485,380 $ 52 874,261 (389,480) 547
Beginning Balance, Shares at Dec. 31, 2023   52,280,077      
Exercise of stock options, value 4,605 $ 1 4,604    
Exercise of stock options, shares   567,097      
Issuance of common stock from vesting of restricted stock, shares   440,816      
Share-based compensation 14,845   14,845    
Unrealized gain (loss) on marketable securities (1,059)       (1,059)
Net Income (Loss) (7,198)     (7,198)  
Ending Balance at Mar. 31, 2024 496,573 $ 53 893,710 (396,678) (512)
Ending Balance, shares at Mar. 31, 2024   53,287,990      
Beginning Balance at Dec. 31, 2023 485,380 $ 52 874,261 (389,480) 547
Beginning Balance, Shares at Dec. 31, 2023   52,280,077      
Net Income (Loss) (60,267)        
Ending Balance at Sep. 30, 2024 483,018 $ 53 930,813 (449,747) 1,899
Ending Balance, shares at Sep. 30, 2024   53,994,996      
Beginning Balance at Mar. 31, 2024 496,573 $ 53 893,710 (396,678) (512)
Beginning Balance, Shares at Mar. 31, 2024   53,287,990      
Exercise of stock options, value 2,288   2,288    
Exercise of stock options, shares   274,334      
Issuance of common stock from vesting of restricted stock, shares   53,606      
Issuance of common stock pursuant to employee stock purchase plan, value 646   646    
Issuance of common stock pursuant to employee stock purchase plan, Shares   15,214      
Share-based compensation 15,139   15,139    
Unrealized gain (loss) on marketable securities (280)       (280)
Net Income (Loss) (27,202)     (27,202)  
Ending Balance at Jun. 30, 2024 487,164 $ 53 911,783 (423,880) (792)
Ending Balance, shares at Jun. 30, 2024   53,631,144      
Exercise of stock options, value 3,697   3,697    
Exercise of stock options, shares   344,018      
Issuance of common stock from vesting of restricted stock, shares   19,834      
Share-based compensation 15,333   15,333    
Unrealized gain (loss) on marketable securities 2,691       2,691
Net Income (Loss) (25,867)     (25,867)  
Ending Balance at Sep. 30, 2024 $ 483,018 $ 53 $ 930,813 $ (449,747) $ 1,899
Ending Balance, shares at Sep. 30, 2024   53,994,996